Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine vs Leflunomide in RA Failing Methotrexate
NCT02930343Phase 3Terminated
- Sponsor
- JIPMER
- Start
- Sep 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of leflunomide in rheumatoid arthritis (RA), sponsored by JIPMER. Started Sep 2016; status: terminated.
02
Drugs
leflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02930343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02930343.